{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:58:20Z","timestamp":1788818300798,"version":"build-2803163510"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:00:00Z","timestamp":1507766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:00:00Z","timestamp":1507766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R43\/R44 AI103983"],"award-info":[{"award-number":["R43\/R44 AI103983"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1097535"],"award-info":[{"award-number":["OPP1097535"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00436-017-5634-4","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T06:42:02Z","timestamp":1507790522000},"page":"3175-3188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80\/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium"],"prefix":"10.1007","volume":"116","author":[{"given":"Adebayo J.","family":"Molehin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souad R.","family":"Sennoune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan U.","family":"Rojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif J.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlie A.","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Sudduth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afzal A.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,12]]},"reference":[{"issue":"3","key":"5634_CR1","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1365-3024.2008.01091.x","volume":"31","author":"G Ahmad","year":"2009","unstructured":"Ahmad G, Torben W, Zhang W, Wyatt M, Siddiqui AA (2009a) Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni. Parasite Immunol 31(3):156\u2013161. https:\/\/doi.org\/10.1111\/j.1365-3024.2008.01091.x","journal-title":"Parasite Immunol"},{"issue":"21","key":"5634_CR2","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1016\/j.vaccine.2009.02.096","volume":"27","author":"G Ahmad","year":"2009","unstructured":"Ahmad G et al (2009b) Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model. Vaccine 27(21):2830\u20132837. https:\/\/doi.org\/10.1016\/j.vaccine.2009.02.096","journal-title":"Vaccine"},{"issue":"6","key":"5634_CR3","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s00436-009-1646-z","volume":"105","author":"G Ahmad","year":"2009","unstructured":"Ahmad G et al (2009c) Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine. Parasitol Res 105(6):1767\u20131777. https:\/\/doi.org\/10.1007\/s00436-009-1646-z","journal-title":"Parasitol Res"},{"issue":"1","key":"5634_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1046\/j.1365-2567.1999.00661.x","volume":"96","author":"S Anderson","year":"1999","unstructured":"Anderson S, Coulson PS, Ljubojevic S, Mountford AP, Wilson RA (1999) The radiation-attenuated schistosome vaccine induces high levels of protective immunity in the absence of B cells. Immunology 96(1):22\u201328","journal-title":"Immunology"},{"issue":"23","key":"5634_CR5","doi-asserted-by":"crossref","first-page":"15085","DOI":"10.1016\/S0021-9258(18)98590-X","volume":"266","author":"K Andresen","year":"1991","unstructured":"Andresen K, Tom TD, Strand M (1991) Characterization of cDNA clones encoding a novel calcium-activated neutral proteinase from Schistosoma mansoni. J Biol Chem 266(23):15085\u201315090","journal-title":"J Biol Chem"},{"issue":"7","key":"5634_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.2471\/BLT.14.143065","volume":"93","author":"JM Angeles","year":"2015","unstructured":"Angeles JM et al (2015) Water buffalo as sentinel animals for schistosomiasis surveillance. Bull World Health Organ 93(7):511\u2013512. https:\/\/doi.org\/10.2471\/BLT.14.143065","journal-title":"Bull World Health Organ"},{"issue":"8","key":"5634_CR7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/archdischild-2012-302338","volume":"98","author":"MA Barry","year":"2013","unstructured":"Barry MA, Simon GG, Mistry N, Hotez PJ (2013) Global trends in neglected tropical disease control and elimination: impact on child health. Arch Dis Child 98(8):635\u2013641. https:\/\/doi.org\/10.1136\/archdischild-2012-302338","journal-title":"Arch Dis Child"},{"issue":"2","key":"5634_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1074\/mcp.M500287-MCP200","volume":"5","author":"S Braschi","year":"2006","unstructured":"Braschi S, Wilson RA (2006) Proteins exposed at the adult schistosome surface revealed by biotinylation. Mol Cell Proteomics 5(2):347\u2013356. https:\/\/doi.org\/10.1074\/mcp.M500287-MCP200","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"5634_CR9","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4269\/ajtmh.1979.28.274","volume":"28","author":"JE Byram","year":"1979","unstructured":"Byram JE, Doenhoff MJ, Musallam R, Brink LH, von Lichtenberg F (1979) Schistosoma mansoni infections in T-cell deprived mice, and the ameliorating effect of administering homologous chronic infection serum. II. Pathology. Am J Trop Med Hyg 28(2):274\u2013285","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"5634_CR10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/imm.12105","volume":"139","author":"D Chen","year":"2013","unstructured":"Chen D, Luo X, Xie H, Gao Z, Fang H, Huang J (2013) Characteristics of IL-17 induction by Schistosoma japonicum infection in C57BL\/6 mouse liver. Immunology 139(4):523\u2013532. https:\/\/doi.org\/10.1111\/imm.12105","journal-title":"Immunology"},{"issue":"1","key":"5634_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016333","volume":"6","author":"RN Coler","year":"2011","unstructured":"Coler RN et al (2011) Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant. PLoS One 6(1):e16333. https:\/\/doi.org\/10.1371\/journal.pone.0016333","journal-title":"PLoS One"},{"issue":"8","key":"5634_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/pim.12087","volume":"36","author":"DG Colley","year":"2014","unstructured":"Colley DG, Secor WE (2014) Immunology of human schistosomiasis. Parasite Immunol 36(8):347\u2013357. https:\/\/doi.org\/10.1111\/pim.12087","journal-title":"Parasite Immunol"},{"issue":"9936","key":"5634_CR13","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","volume":"383","author":"DG Colley","year":"2014","unstructured":"Colley DG, Bustinduy AL, Secor WE, King CH (2014) Human schistosomiasis. Lancet 383(9936):2253\u20132264. https:\/\/doi.org\/10.1016\/S0140-6736(13)61949-2","journal-title":"Lancet"},{"key":"5634_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1385\/1-59745-168-1:171","volume":"127","author":"CJ Dale","year":"2006","unstructured":"Dale CJ et al (2006) Prime-boost strategies in DNA vaccines. Methods Mol Med 127:171\u2013197. https:\/\/doi.org\/10.1385\/1-59745-168-1:171","journal-title":"Methods Mol Med"},{"issue":"3","key":"5634_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4161\/hv.2940","volume":"2","author":"R De Rose","year":"2006","unstructured":"De Rose R et al (2006) Dose-response relationship of DNA and recombinant fowlpox virus prime-boost HIV vaccines: implications for future trials. Hum Vaccin 2(3):134\u2013136","journal-title":"Hum Vaccin"},{"issue":"2","key":"5634_CR16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.4269\/ajtmh.1979.28.260","volume":"28","author":"M Doenhoff","year":"1979","unstructured":"Doenhoff M, Musallam R, Bain J, McGregor A (1979) Schistosoma mansoni infections in T-cell deprived mice, and the ameliorating effect of administering homologous chronic infection serum. I. Pathogenesis. Am J Trop Med Hyg 28(2):260\u2013263","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"5634_CR17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1645\/GE-3186.1","volume":"99","author":"R El Ridi","year":"2013","unstructured":"El Ridi R, Tallima H (2013) Vaccine-induced protection against murine schistosomiasis mansoni with larval excretory-secretory antigens and papain or type-2 cytokines. J Parasitol 99(2):194\u2013202. https:\/\/doi.org\/10.1645\/GE-3186.1","journal-title":"J Parasitol"},{"key":"5634_CR18","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3389\/fimmu.2015.00390","volume":"6","author":"R El Ridi","year":"2015","unstructured":"El Ridi R, Othman AA, McManus DP (2015) Editorial: The schistosomiasis vaccine\u2014it is time to stand up. Front Immunol 6:390. https:\/\/doi.org\/10.3389\/fimmu.2015.00390","journal-title":"Front Immunol"},{"issue":"2 Suppl","key":"5634_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4269\/ajtmh.2000.62.88","volume":"62","author":"T El-Khoby","year":"2000","unstructured":"El-Khoby T et al (2000) The epidemiology of schistosomiasis in Egypt: summary findings in nine governorates. Am J Trop Med Hyg 62(2 Suppl):88\u201399","journal-title":"Am J Trop Med Hyg"},{"key":"5634_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3389\/fimmu.2015.00095","volume":"6","author":"CT Fonseca","year":"2015","unstructured":"Fonseca CT, Oliveira SC, Alves CC (2015) Eliminating schistosomes through vaccination: what are the best immune weapons? Front Immunol 6:95. https:\/\/doi.org\/10.3389\/fimmu.2015.00095","journal-title":"Front Immunol"},{"issue":"1\u20132","key":"5634_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","volume":"221","author":"A Frey","year":"1998","unstructured":"Frey A, Di Canzio J, Zurakowski D (1998) A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods 221(1\u20132):35\u201341","journal-title":"J Immunol Methods"},{"issue":"9","key":"5634_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1365-3024.2005.00785.x","volume":"27","author":"LM Ganley-Leal","year":"2005","unstructured":"Ganley-Leal LM et al (2005) Comparison of Schistosoma mansoni irradiated cercariae and Sm23 DNA vaccines. Parasite Immunol 27(9):341\u2013349. https:\/\/doi.org\/10.1111\/j.1365-3024.2005.00785.x","journal-title":"Parasite Immunol"},{"issue":"4","key":"5634_CR23","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1586\/erv.11.29","volume":"10","author":"N Garcon","year":"2011","unstructured":"Garcon N, Van Mechelen M (2011) Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems. Expert Rev Vaccines 10(4):471\u2013486. https:\/\/doi.org\/10.1586\/erv.11.29","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"5634_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/00034983.1978.11719309","volume":"72","author":"AM Ghandour","year":"1978","unstructured":"Ghandour AM (1978) The development of Schistosoma haematobium in the hamster. Ann Trop Med Parasitol 72(3):219\u2013225","journal-title":"Ann Trop Med Parasitol"},{"issue":"9","key":"5634_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001778","volume":"6","author":"CA Gordon","year":"2012","unstructured":"Gordon CA et al (2012) High prevalence of Schistosoma japonicum infection in carabao from Samar Province, the Philippines: implications for transmission and control. PLoS Negl Trop Dis 6(9):e1778. https:\/\/doi.org\/10.1371\/journal.pntd.0001778","journal-title":"PLoS Negl Trop Dis"},{"issue":"9541","key":"5634_CR26","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S0140-6736(06)69440-3","volume":"368","author":"B Gryseels","year":"2006","unstructured":"Gryseels B, Polman K, Clerinx J, Kestens L (2006) Human schistosomiasis. Lancet 368(9541):1106\u20131118. https:\/\/doi.org\/10.1016\/S0140-6736(06)69440-3","journal-title":"Lancet"},{"issue":"7","key":"5634_CR27","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.pt.2014.05.004","volume":"30","author":"J Honeycutt","year":"2014","unstructured":"Honeycutt J, Hammam O, CL F, Hsieh MH (2014) Controversies and challenges in research on urogenital schistosomiasis-associated bladder cancer. Trends Parasitol 30(7):324\u2013332. https:\/\/doi.org\/10.1016\/j.pt.2014.05.004","journal-title":"Trends Parasitol"},{"issue":"6","key":"5634_CR28","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/clpt.2009.16","volume":"85","author":"PJ Hotez","year":"2009","unstructured":"Hotez PJ (2009) Mass drug administration and integrated control for the world\u2019s high-prevalence neglected tropical diseases. Clin Pharmacol Ther 85(6):659\u2013664. https:\/\/doi.org\/10.1038\/clpt.2009.16","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"5634_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002865","volume":"8","author":"PJ Hotez","year":"2014","unstructured":"Hotez PJ et al (2014) The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis 8(7):e2865. https:\/\/doi.org\/10.1371\/journal.pntd.0002865","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"5634_CR30","doi-asserted-by":"crossref","first-page":"806","DOI":"10.4049\/jimmunol.157.2.806","volume":"157","author":"D Jankovic","year":"1996","unstructured":"Jankovic D et al (1996) Calpain is the target antigen of a Th1 clone that transfers protective immunity against Schistosoma mansoni. J Immunol 157(2):806\u2013814","journal-title":"J Immunol"},{"issue":"11","key":"5634_CR31","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.vaccine.2013.12.057","volume":"32","author":"S Karmakar","year":"2014","unstructured":"Karmakar S et al (2014a) Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons. Vaccine 32(11):1296\u20131303. https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.057","journal-title":"Vaccine"},{"issue":"12","key":"5634_CR32","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1093\/infdis\/jiu031","volume":"209","author":"S Karmakar","year":"2014","unstructured":"Karmakar S et al (2014b) Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons. J Infect Dis 209(12):1929\u20131940. https:\/\/doi.org\/10.1093\/infdis\/jiu031","journal-title":"J Infect Dis"},{"issue":"1","key":"5634_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/0014-4894(77)90131-X","volume":"41","author":"PM Knopf","year":"1977","unstructured":"Knopf PM, Nutman TB, Reasoner JA (1977) Schistosoma mansoni: resistance to reinfection in the rat. Exp Parasitol 41(1):74\u201382","journal-title":"Exp Parasitol"},{"issue":"1","key":"5634_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.exppara.2004.11.001","volume":"109","author":"T Kumagai","year":"2005","unstructured":"Kumagai T et al (2005) Schistosoma japonicum: localization of calpain in the penetration glands and secretions of cercariae. Exp Parasitol 109(1):53\u201357. https:\/\/doi.org\/10.1016\/j.exppara.2004.11.001","journal-title":"Exp Parasitol"},{"issue":"3","key":"5634_CR35","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00436-014-3757-4","volume":"113","author":"L Le","year":"2014","unstructured":"Le L, Zhang W, Karmakar S, Ahmad G, Torben W, Siddiqui AA (2014) Simultaneous priming with DNA encoding Sm-p80 and boosting with Sm-p80 protein confers protection against challenge infection with Schistosoma mansoni in mice. Parasitol Res 113(3):1195\u20131200. https:\/\/doi.org\/10.1007\/s00436-014-3757-4","journal-title":"Parasitol Res"},{"issue":"7","key":"5634_CR36","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.4049\/jimmunol.136.7.2644","volume":"136","author":"BL Mangold","year":"1986","unstructured":"Mangold BL, Dean DA (1986) Passive transfer with serum and IgG antibodies of irradiated cercaria-induced resistance against Schistosoma mansoni in mice. J Immunol 136(7):2644\u20132648","journal-title":"J Immunol"},{"issue":"2","key":"5634_CR37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0022-1759(98)00015-5","volume":"212","author":"RM Martin","year":"1998","unstructured":"Martin RM, Brady JL, Lew AM (1998) The need for IgG2c specific antiserum when isotyping antibodies from C57BL\/6 and NOD mice. J Immunol Methods 212(2):187\u2013192","journal-title":"J Immunol Methods"},{"issue":"1","key":"5634_CR38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1128\/CMR.00046-07","volume":"21","author":"DP McManus","year":"2008","unstructured":"McManus DP, Loukas A (2008) Current status of vaccines for schistosomiasis. Clin Microbiol Rev 21(1):225\u2013242. https:\/\/doi.org\/10.1128\/CMR.00046-07","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"5634_CR39","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1128\/CMR.00044-09","volume":"23","author":"DP McManus","year":"2010","unstructured":"McManus DP et al (2010) Schistosomiasis in the People\u2019s Republic of China: the era of the Three Gorges Dam. Clin Microbiol Rev 23(2):442\u2013466. https:\/\/doi.org\/10.1128\/CMR.00044-09","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"5634_CR40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/pim.12091","volume":"36","author":"TT Melo","year":"2014","unstructured":"Melo TT, Sena IC, Araujo N, Fonseca CT (2014) Antibodies are involved in the protective immunity induced in mice by Schistosoma mansoni schistosomula tegument (Smteg) immunization. Parasite Immunol 36(2):107\u2013111","journal-title":"Parasite Immunol"},{"issue":"1","key":"5634_CR41","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4269\/ajtmh.13-0467","volume":"90","author":"AX Mo","year":"2014","unstructured":"Mo AX, Agosti JM, Walson JL, Hall BF, Gordon L (2014) Schistosomiasis elimination strategies and potential role of a vaccine in achieving global health goals. Am J Trop Med Hyg 90(1):54\u201360. https:\/\/doi.org\/10.4269\/ajtmh.13-0467","journal-title":"Am J Trop Med Hyg"},{"key":"5634_CR42","doi-asserted-by":"publisher","unstructured":"Molehin AJ, Rojo JU, Siddiqui SZ, Gray SA, Carter D, Siddiqui AA (2016) Development of a schistosomiasis vaccine. Expert Rev Vaccines: 1\u20139. https:\/\/doi.org\/10.1586\/14760584.2016.1131127","DOI":"10.1586\/14760584.2016.1131127"},{"key":"5634_CR43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","volume":"7","author":"TR Mosmann","year":"1989","unstructured":"Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145\u2013173. https:\/\/doi.org\/10.1146\/annurev.iy.07.040189.001045","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"5634_CR44","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.parint.2004.01.007","volume":"53","author":"N Ohta","year":"2004","unstructured":"Ohta N, Kumagai T, Maruyama H, Yoshida A, He Y, Zhang R (2004) Research on calpain of Schistosoma japonicum as a vaccine candidate. Parasitol Int 53(2):175\u2013181. https:\/\/doi.org\/10.1016\/j.parint.2004.01.007","journal-title":"Parasitol Int"},{"issue":"5","key":"5634_CR45","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1046\/j.1365-3024.2001.00379.x","volume":"23","author":"Y Osada","year":"2001","unstructured":"Osada Y et al (2001) Protective immunity to Schistosoma japonicum infection depends on the balance of T helper cytokine responses in mice vaccinated with gamma-irradiated cercariae. Parasite Immunol 23(5):251\u2013258","journal-title":"Parasite Immunol"},{"issue":"7","key":"5634_CR46","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri843","volume":"2","author":"EJ Pearce","year":"2002","unstructured":"Pearce EJ, MacDonald AS (2002) The immunobiology of schistosomiasis. Nat Rev Immunol 2(7):499\u2013511. https:\/\/doi.org\/10.1038\/nri843","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"5634_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001564","volume":"6","author":"MS Pearson","year":"2012","unstructured":"Pearson MS et al (2012) Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2. PLoS Negl Trop Dis 6(3):e1564. https:\/\/doi.org\/10.1371\/journal.pntd.0001564","journal-title":"PLoS Negl Trop Dis"},{"key":"5634_CR48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12879-016-1444-z","volume":"16","author":"A Ricciardi","year":"2016","unstructured":"Ricciardi A, Visitsunthorn K, Dalton JP, Ndao M (2016) A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis. BMC Infect Dis 16:112. https:\/\/doi.org\/10.1186\/s12879-016-1444-z","journal-title":"BMC Infect Dis"},{"issue":"6","key":"5634_CR49","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/infdis\/jiu527","volume":"211","author":"G Rinaldi","year":"2015","unstructured":"Rinaldi G, Young ND, Honeycutt JD, Brindley PJ, Gasser RB, Hsieh MH (2015) New research tools for urogenital schistosomiasis. J Infect Dis 211(6):861\u2013869. https:\/\/doi.org\/10.1093\/infdis\/jiu527","journal-title":"J Infect Dis"},{"issue":"32","key":"5634_CR50","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1016\/S0264-410X(01)00260-2","volume":"19","author":"J Schneider","year":"2001","unstructured":"Schneider J et al (2001) A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees. Vaccine 19(32):4595\u20134602","journal-title":"Vaccine"},{"issue":"4","key":"5634_CR51","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.4049\/jimmunol.128.4.1880","volume":"128","author":"A Sher","year":"1982","unstructured":"Sher A, Hieny S, James SL, Asofsky R (1982) Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. II. Analysis of immunity in hosts deficient in T lymphocytes, B lymphocytes, or complement. J Immunol 128(4):1880\u20131884","journal-title":"J Immunol"},{"issue":"1","key":"5634_CR52","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0925-4439(93)90087-H","volume":"1181","author":"AA Siddiqui","year":"1993","unstructured":"Siddiqui AA et al (1993) Characterization of Ca(2+)-dependent neutral protease (calpain) from human blood flukes, Schistosoma mansoni. Biochim Biophys Acta 1181(1):37\u201344","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"5634_CR53","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.4049\/jimmunol.163.8.4489","volume":"163","author":"M Street","year":"1999","unstructured":"Street M et al (1999) TNF is essential for the cell-mediated protective immunity induced by the radiation-attenuated schistosome vaccine. J Immunol 163(8):4489\u20134494","journal-title":"J Immunol"},{"issue":"9","key":"5634_CR54","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.1128\/IAI.69.9.5403-5411.2001","volume":"69","author":"A Tanghe","year":"2001","unstructured":"Tanghe A, Content J, Van Vooren JP, Portaels F, Huygen K (2001a) Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer. Infect Immun 69(9):5403\u20135411","journal-title":"Infect Immun"},{"issue":"5","key":"5634_CR55","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1128\/IAI.69.5.3041-3047.2001","volume":"69","author":"A Tanghe","year":"2001","unstructured":"Tanghe A et al (2001b) Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infect Immun 69(5):3041\u20133047. https:\/\/doi.org\/10.1128\/IAI.69.5.3041-3047.2001","journal-title":"Infect Immun"},{"issue":"12","key":"5634_CR56","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1016\/j.vaccine.2011.01.040","volume":"29","author":"W Torben","year":"2011","unstructured":"Torben W, Ahmad G, Zhang W, Siddiqui AA (2011) Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models. Vaccine 29(12):2262\u20132271. https:\/\/doi.org\/10.1016\/j.vaccine.2011.01.040","journal-title":"Vaccine"},{"issue":"48","key":"5634_CR57","doi-asserted-by":"publisher","first-page":"6753","DOI":"10.1016\/j.vaccine.2012.09.026","volume":"30","author":"W Torben","year":"2012","unstructured":"Torben W et al (2012) Role of antibody dependent cell mediated cytotoxicity (ADCC) in Sm-p80-mediated protection against Schistosoma mansoni. Vaccine 30(48):6753\u20136758. https:\/\/doi.org\/10.1016\/j.vaccine.2012.09.026","journal-title":"Vaccine"},{"key":"5634_CR58","doi-asserted-by":"publisher","unstructured":"Tucker MS, Karunaratne LB, Lewis FA, Freitas TC, Liang YS (2013) Schistosomiasis. Curr Protoc Immunol 103:Unit 19 1. https:\/\/doi.org\/10.1002\/0471142735.im1901s103","DOI":"10.1002\/0471142735.im1901s103"},{"issue":"2\u20133","key":"5634_CR59","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0001-706X(03)00029-9","volume":"86","author":"MJ van der Werf","year":"2003","unstructured":"van der Werf MJ et al (2003) Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 86(2\u20133):125\u2013139","journal-title":"Acta Trop"},{"issue":"6","key":"5634_CR60","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1128\/IAI.72.6.3336-3343.2004","volume":"72","author":"PB Varaldo","year":"2004","unstructured":"Varaldo PB et al (2004) Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge. Infect Immun 72(6):3336\u20133343. https:\/\/doi.org\/10.1128\/IAI.72.6.3336-3343.2004","journal-title":"Infect Immun"},{"issue":"4","key":"5634_CR61","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/0035-9203(94)90436-7","volume":"88","author":"IR Viana","year":"1994","unstructured":"Viana IR et al (1994) Interferon-gamma production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni. Trans R Soc Trop Med Hyg 88(4):466\u2013470","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"5634_CR62","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1046\/j.1365-3156.1996.d01-52.x","volume":"1","author":"PN Vuong","year":"1996","unstructured":"Vuong PN, Bayssade-Dufour C, Albaret JL, Farhati K (1996) Histopathological observations in new and classic models of experimental Schistosoma haematobium infections. Tropical Med Int Health 1(3):348\u2013358","journal-title":"Tropical Med Int Health"},{"issue":"3","key":"5634_CR63","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00436-006-0150-y","volume":"99","author":"W Wang","year":"2006","unstructured":"Wang W, Kirschfink M, Ruppel A (2006) Schistosoma japonicum and S. mansoni cercariae: different effects of protein in medium, of mechanical stress, and of an intact complement system on in vitro transformation to schistosomula. Parasitol Res 99(3):269\u2013274. https:\/\/doi.org\/10.1007\/s00436-006-0150-y","journal-title":"Parasitol Res"},{"issue":"9","key":"5634_CR64","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.pt.2009.05.011","volume":"25","author":"RA Wilson","year":"2009","unstructured":"Wilson RA, Coulson PS (2009) Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour. Trends Parasitol 25(9):423\u2013431. https:\/\/doi.org\/10.1016\/j.pt.2009.05.011","journal-title":"Trends Parasitol"},{"issue":"1\u20132","key":"5634_CR65","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0165-2478(98)00134-5","volume":"65","author":"RA Wilson","year":"1999","unstructured":"Wilson RA, Coulson PS, Mountford AP (1999) Immune responses to the radiation-attenuated schistosome vaccine: what can we learn from knock-out mice? Immunol Lett 65(1\u20132):117\u2013123","journal-title":"Immunol Lett"},{"issue":"9","key":"5634_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000290","volume":"2","author":"RA Wilson","year":"2008","unstructured":"Wilson RA et al (2008) Elimination of Schistosoma mansoni adult worms by rhesus macaques: basis for a therapeutic vaccine? PLoS Negl Trop Dis 2(9):e290. https:\/\/doi.org\/10.1371\/journal.pntd.0000290","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"5634_CR67","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13071-016-1369-9","volume":"9","author":"RA Wilson","year":"2016","unstructured":"Wilson RA, Li XH, Castro-Borges W (2016) Do schistosome vaccine trials in mice have an intrinsic flaw that generates spurious protection data? Parasit Vectors 9(1):89. https:\/\/doi.org\/10.1186\/s13071-016-1369-9","journal-title":"Parasit Vectors"},{"issue":"4","key":"5634_CR68","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S1674-8301(10)60039-5","volume":"24","author":"M Zhang","year":"2010","unstructured":"Zhang M, Tian F, Gao Y, Ji M, Wu G (2010a) Ultraviolet- attenuated cercariae of Schistosoma japonicum fail to effectively induce a Th1 response in spite of up-regulating expression of cytotoxicity-related genes in C57BL\/6 mice. J Biomed Res 24(4):277\u2013284. https:\/\/doi.org\/10.1016\/S1674-8301(10)60039-5","journal-title":"J Biomed Res"},{"issue":"7","key":"5634_CR69","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1086\/651147","volume":"201","author":"W Zhang","year":"2010","unstructured":"Zhang W et al (2010b) Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine. J Infect Dis 201(7):1105\u20131112. https:\/\/doi.org\/10.1086\/651147","journal-title":"J Infect Dis"},{"issue":"2","key":"5634_CR70","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.actatropica.2011.01.010","volume":"118","author":"W Zhang","year":"2011","unstructured":"Zhang W, Ahmad G, Torben W, Siddiqui AA (2011) Schistosoma mansoni antigen Sm-p80: prophylactic efficacy of a vaccine formulated in human approved plasmid vector and adjuvant (VR 1020 and alum). Acta Trop 118(2):142\u2013151. https:\/\/doi.org\/10.1016\/j.actatropica.2011.01.010","journal-title":"Acta Trop"},{"issue":"6","key":"5634_CR71","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1002\/eji.201141933","volume":"42","author":"Y Zhang","year":"2012","unstructured":"Zhang Y et al (2012) IL-17 neutralization significantly ameliorates hepatic granulomatous inflammation and liver damage in Schistosoma japonicum infected mice. Eur J Immunol 42(6):1523\u20131535. https:\/\/doi.org\/10.1002\/eji.201141933","journal-title":"Eur J Immunol"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-017-5634-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-017-5634-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-017-5634-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:08:56Z","timestamp":1744175336000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-017-5634-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,12]]},"references-count":71,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["5634"],"URL":"https:\/\/doi.org\/10.1007\/s00436-017-5634-4","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,12]]},"assertion":[{"value":"29 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. All animal procedures were conducted in accordance with Institutional Animal Care and Use Committee (IACUC) Guidelines and were approved by the Animal Ethics Committee at Texas Tech University Health Sciences Center.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}